Hemagen Diagnostics (Hemagen Diagnostics) Receivables Turnover : 1.49 (As of Sep. 2012)

View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Hemagen Diagnostics's Revenue for the three months ended in Sep. 2012 was $0.88 Mil. Hemagen Diagnostics's average Accounts Receivable for the three months ended in Sep. 2012 was $0.59 Mil. Hence, Hemagen Diagnostics's Receivables Turnover for the three months ended in Sep. 2012 was 1.49.

Hemagen Diagnostics Receivables Turnover Historical Data

The historical data trend for Hemagen Diagnostics's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Receivables Turnover Chart

Hemagen Diagnostics Annual Data

Trend

Sep03

Sep04

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Receivables Turnover

Get a 7-Day Free Trial

6.83

7.24

8.03

8.23

6.92

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
Receivables Turnover	Get a 7-Day Free Trial															1.88	2.22	2.20	1.61	1.49

Competitive Comparison of Hemagen Diagnostics's Receivables Turnover

For the Biotechnology subindustry, Hemagen Diagnostics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemagen Diagnostics's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's Receivables Turnover falls into.

Hemagen Diagnostics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Hemagen Diagnostics's Receivables Turnover for the fiscal year that ended in Sep. 2012 is calculated as

	Receivables Turnover (A: Sep. 2012 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Sep. 2012 )	/ (	(Accounts Receivable (A: Sep. 2011 )	+	Accounts Receivable (A: Sep. 2012 ))	/	count )
=	4.042	/ (	(0.58	+	0.588)	/	2 )
=	4.042	/	0.584
=	6.92

Hemagen Diagnostics's Receivables Turnover for the quarter that ended in Sep. 2012 is calculated as

	Receivables Turnover (Q: Sep. 2012 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Sep. 2012 )	/ (	(Accounts Receivable (Q: Jun. 2012 )	+	Accounts Receivable (Q: Sep. 2012 ))	/	count )
=	0.876	/ (	(0.585	+	0.588)	/	2 )
=	0.876	/	0.5865
=	1.49

Hemagen Diagnostics (OTCPK:HMGN) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Hemagen Diagnostics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

9033 Red Branch Road, Columbia, MD, USA, 21045

Website

http://www.hemagen.com

Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.

Executives

Howard F Curd

director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines